AG
Highly rated in
13
conditions
Highly rated in
13
conditions
Check Dr. Abhimanyu K. Garg's experience treating your condition:
About Dr. Abhimanyu K. Garg

Abhimanyu Garg is an Endocrinologist in Dallas, Texas. Garg has been practicing medicine for over 41 years and is highly rated in 13 conditions, according to our data. His top areas of expertise are Congenital Generalized Lipodystrophy, Familial Partial Lipodystrophy, Gigantism, Mandibuloacral Dysplasia, and Gastric Bypass. He is licensed to treat patients in Texas. Garg is currently accepting new patients.

His clinical research consists of co-authoring 107 peer reviewed articles and participating in 13 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Abhimanyu K. Garg it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Abhimanyu K. Garg accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
2001 Inwood Rd, Dallas, TX 75390
Other Locations
5303 Harry Hines Blvd, Dallas, TX 75390
Background & Education
Graduate Institution
Other, 1981
Specialties
Endocrinology
Licenses
Internal Medicine in TX
Hospital Affiliations
Parkland Health And Hospital System
Dallas VA Medical Center
William P Clements Jr University Hospital
Languages Spoken
English
Hindi
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

MEASuRE: Metreleptin Effectiveness And Safety Registry
Novel Therapies for Metabolic Complications in Patients With Lipodystrophies
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Double-Blind, Placebo-Controlled Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients
A 36-Month, Multicenter, Open Label Phase 4 Study to Evaluate the Immunogenicity of Daily SC Metreleptin Treatment in Patients With Generalized Lipodystrophy
Open Label Single Center Pilot Study to Study Teh Effects of Metreleptin Administration in Patients With Type 1 Diabetes Mellitus ( T1DM ).
The Study of Mechanisms of Lipodystrophy in HIV-Infected Patients
Mecahnisms of Lipodystrophy in HIV-Infected Patients
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Effect of Dietary Fiber on Glucose, Lipid, and Mineral Metabolism in Patients With Non Insulin Dependent Diabetes Mellitus
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Therapeutic Approaches to HAART-Induced Lipodystrophy
View 12 Less Clinical Trials -

107 Total Publications

Lipodystrophy for the Diabetologist-What to Look For.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors